{"id":3412,"date":"2024-08-23T10:53:35","date_gmt":"2024-08-23T08:53:35","guid":{"rendered":"https:\/\/semmelweis.hu\/tmk\/?p=3412"},"modified":"2025-11-21T12:46:52","modified_gmt":"2025-11-21T11:46:52","slug":"valikovics-aniko-katalin","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/tmk\/2024\/08\/23\/valikovics-aniko-katalin\/","title":{"rendered":"Valikovics Anik\u00f3 Katalin"},"content":{"rendered":"<div style=\"margin-bottom: 20px\">\n<h3 style=\"color: #232f61\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-6332 alignleft\" src=\"https:\/\/semmelweis.hu\/tmk\/files\/2024\/08\/Valikovics-A.png\" alt=\"\" width=\"200\" height=\"300\" \/>TOPIC<\/h3>\n<p style=\"font-size: 1em;color: #424a52\">Systemic Treatments of Metastatic Prostate Cancer.<\/p>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n<h3 style=\"color: #232f61\">VISION<\/h3>\n<p style=\"font-size: 1em;color: #424a52\">Patients having the best treatment option for metastatic prostate cancer.<\/p>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n<h3 style=\"color: #232f61\">MISSION<\/h3>\n<p style=\"font-size: 1em;color: #424a52\">Finding the drug that significantly improves the quality of life of patients.<\/p>\n<\/div>\n<div style=\"margin-bottom: 10px\">\n<h4 style=\"color: #232f61\">PROJECT TITLE 1<\/h4>\n<p style=\"font-size: 1em;color: #424a52\">Investigating the efficacy and safety of abiraterone and enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.<\/p>\n<\/div>\n<div style=\"margin-bottom: 10px\">\n<h4 style=\"color: #232f61\">PROJECT TITLE 2<\/h4>\n<p style=\"font-size: 1em;color: #424a52\">Investigating the efficacy and safety of abiraterone, apalutamide and enzalutamide in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.<\/p>\n<h4 style=\"color: #232f61\">PROJECT TITLE 3<\/h4>\n<p style=\"font-size: 1em;color: #424a52\">Identifying patients with metastatic prostate cancer who benefit from PSMA- radioligand therapy: a systematic review and meta-analysis.<\/p>\n<\/div>\n<div id=\"myModal\" class=\"modal fade single-modal-csekk\" tabindex=\"-1\" role=\"dialog\" \r\n     aria-labelledby=\"myModalLabel\" aria-hidden=\"true\">\r\n    <div class=\"modal-dialog\">\r\n        <div class=\"modal-content\">\r\n            <div class=\"modal-body\">\r\n                <button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\" aria-hidden=\"true\">&times;<\/button>\r\n                <div class=\"modal-video\">\r\n                    <div class=\"embed-responsive embed-responsive-16by9\">\r\n                        <iframe sandbox=\"allow-scripts allow-same-origin allow-presentation\" id=\"ytplayer\" class=\"embed-responsive-item\" frameborder=\"0\" allow=\"encrypted-media;autoplay\" allowfullscreen><\/iframe>\r\n                    <\/div>\r\n                <\/div>\r\n            <\/div>\r\n        <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n<script>\r\n    jQuery(document).ready(function(){\r\n        jQuery('.modal-backdrop').click(function () {\r\n            jQuery('#myModal').modal('hide');\r\n        });\r\n        \/\/ONLY ALLOW ONE MODAL WITH THIS ID!\r\n        $('#myModal').each(function (i) {\r\n                $('[id=\"' + this.id + '\"]').slice(1).remove();\r\n        });\r\n    });\r\n    jQuery('#myModal').on('hidden.bs.modal', function (e) {\r\n        jQuery('#myModal iframe').removeAttr('src');            \r\n    });\r\n\r\n<\/script>\r\n\r\n<section style=\"background-color: white !important\">\r\n    <style>\r\n    .yt-slider .section-link h5:after {\r\n        color: unset !important;\r\n    }\r\n\r\n\r\n\r\n    body:not(.sidebar-primary) videosav .owl-item:not(.center) {\r\n        \/* padding: 0.3%; *\/\r\n    }\r\n\r\n    videosav .owl-item:not(.center) {\r\n        padding: 15px;\r\n    }\r\n\r\n\r\n    videosav .owl-item.center .card {\r\n        \/* margin-left: -40px;\r\n                margin-right: -40px; *\/\r\n    }\r\n\r\n    videosav .card-body {\r\n        background-color:\r\n             white \r\n        ;\r\n        min-height: 0px;\r\n        padding: 0 !important;\r\n\r\n    }\r\n\r\n    .yt-cim-feher {\r\n        line-height: 25px;\r\n        background: rgb(28 49 90 \/ 50%);\r\n        color: #fff;\r\n        position: absolute;\r\n        left: 0;\r\n        top: -45px;\r\n        min-height: 45px;\r\n        font-size: 14px;\r\n        display: -webkit-box !important;\r\n        -webkit-line-clamp: 2;\r\n        overflow: hidden;\r\n        -webkit-box-orient: vertical;\r\n        min-width: 100%;\r\n        padding-left: 5px;\r\n        padding-right: 5px;\r\n        ;\r\n    }\r\n\r\n    .yt-cim-kek {\r\n        line-height: 25px;\r\n        color: #fff;\r\n        min-height: 45px;\r\n        font-size: 16px;\r\n        display: -webkit-box !important;\r\n        -webkit-line-clamp: 2;\r\n        overflow: hidden;\r\n\r\n        -webkit-box-orient: vertical;\r\n    }\r\n\r\n    videosav.yt-slider .owl-item:not(.center) .yt-cim {\r\n        display: none !important;\r\n    }\r\n\r\n    videosav.yt-slider .owl-item.center .yt-cim {\r\n        padding: 15px !important;\r\n        top: -80px;\r\n        min-height: 80px;\r\n\r\n\r\n    }\r\n\r\n    videosav.yt-slider .owl-item.center {\r\n        margin-top: 0;\r\n    }\r\n\r\n    videosav.yt-slider .owl-item.center a:hover {\r\n        background-color: transparent;\r\n    }\r\n\r\n    videosav.yt-slider .owl-item.center .card .counter {\r\n        display: flex;\r\n        align-content: flex-start;\r\n        justify-content: center;\r\n        align-items: flex-end;\r\n        min-height: 28px;\r\n    }\r\n\r\n    videosav.yt-slider .owl-nav {\r\n        padding-top: 1.5rem;\r\n\r\n\r\n    }\r\n\r\n    videosav.yt-slider .owl-nav button {\r\n        height: calc(100% - 35px);\r\n        margin: 0;\r\n\r\n\r\n    }\r\n\r\n    videosav.yt-slider .owl-item a.videolink.ready {\r\n        height: inherit !important;\r\n        padding-top: unset !important;\r\n        aspect-ratio: 16 \/ 9;\r\n        padding-top: 1%;\r\n        padding-bottom: 1%;\r\n\r\n    }\r\n\r\n    videosav.yt-slider .owl-item .videolink:after {\r\n        \/* top: -30px; *\/\r\n        \/* background-position-y: calc(50% - 28px); *\/\r\n        aspect-ratio: 16 \/ 9;\r\n        height: inherit !important;\r\n    }\r\n\r\n    videosav.yt-slider .owl-item.active.center .videolink:after {\r\n        \/* top: -30px; *\/\r\n        \/* background-position-y: calc(50% - 28px); *\/\r\n        background-position-y: calc(50% + 5px);\r\n\r\n    }\r\n<\/style>\r\n    <div class=\"yt-slider videosav \">\r\n                    <!-- <div class=\"section-row row <?= mt-2 ?> <?php (mt-2 == \"mt-0\" ? \"pt-0\" : \"pt-3\") ?> pl-0 pr-0 mx-lg-0\"\r\n            style=\"background-color: <?= white ?>; padding-top: 10px;\"> -->\r\n            <div class=\"section-row row  mt-2 pt-3  pl-0 pr-0 mx-lg-0\"\r\n            style=\"background-color:  white; padding-top: 10px;\">\r\n            <div class=\"col-md-auto section-title\" style=\"background-color: #1C315A;\">\r\n                <h2 style=\"color: white ;\"> Progress Reports <\/h2>\r\n            <\/div>\r\n            <div class=\"col section-divider px-0 mx-2 d-none d-md-block\"\r\n                style=\"background-color: #1C315A;\"><\/div>\r\n\r\n            <div class=\"col col-md-auto section-link text-uppercase px-0 d-none d-md-block\" style=\"margin-right: 5px;\">\r\n                <h5 class=\"m-0 After-text-white\" style=\"color:  #1C315A  !important;\">\r\n    <a href=\"https:\/\/www.youtube.com\/playlist?list=PLRKA1an--trf2syLdIVmUe1VzTZVm6FCW\"\r\n        style=\"color: #1C315A  !important;\">\r\n            Tov\u00e1bbi vide\u00f3k\r\n    <\/a>\r\n<\/h5>\r\n            <\/div>\r\n        <\/div>\r\n        <div class=\"row px-0  mb-0 mx-lg-0\" style=\"background-color: white\">\r\n\r\n            <div class=\"owl-carousel col-12 px-0 mt-2 mb-3\">\r\n                \r\n<div class=\"card\">\r\n    <div class=\"card-img\">\r\n        <a class=\"videolink\" href=\"https:\/\/www.youtube.com\/watch?v=PMnYBLD64j8\" data-src=\"https:\/\/www.youtube.com\/embed\/PMnYBLD64j8?modestbranding=1&rel=0&controls=1&showinfo=0&html5=1&autoplay=1\"\r\n            style=\"background-image: url(https:\/\/i.ytimg.com\/vi\/PMnYBLD64j8\/maxresdefault.jpg)\">\r\n        <\/a>\r\n    <\/div>\r\n            \r\n    <h6 class=\"counter text-center  text-white\" style=\"color:  #1C315A  !important;\">\r\n        <span class=\"bold\"> 1 <\/span> \/  5\r\n    <\/h6>\r\n\r\n<\/div>\r\n<div class=\"card\">\r\n    <div class=\"card-img\">\r\n        <a class=\"videolink\" href=\"https:\/\/www.youtube.com\/watch?v=0T5-8q01gKU\" data-src=\"https:\/\/www.youtube.com\/embed\/0T5-8q01gKU?modestbranding=1&rel=0&controls=1&showinfo=0&html5=1&autoplay=1\"\r\n            style=\"background-image: url(https:\/\/i.ytimg.com\/vi\/0T5-8q01gKU\/maxresdefault.jpg)\">\r\n        <\/a>\r\n    <\/div>\r\n            \r\n    <h6 class=\"counter text-center  text-white\" style=\"color:  #1C315A  !important;\">\r\n        <span class=\"bold\"> 2 <\/span> \/  5\r\n    <\/h6>\r\n\r\n<\/div>\r\n<div class=\"card\">\r\n    <div class=\"card-img\">\r\n        <a class=\"videolink\" href=\"https:\/\/www.youtube.com\/watch?v=Xdm7Kru7ES4\" data-src=\"https:\/\/www.youtube.com\/embed\/Xdm7Kru7ES4?modestbranding=1&rel=0&controls=1&showinfo=0&html5=1&autoplay=1\"\r\n            style=\"background-image: url(https:\/\/i.ytimg.com\/vi\/Xdm7Kru7ES4\/maxresdefault.jpg)\">\r\n        <\/a>\r\n    <\/div>\r\n            \r\n    <h6 class=\"counter text-center  text-white\" style=\"color:  #1C315A  !important;\">\r\n        <span class=\"bold\"> 3 <\/span> \/  5\r\n    <\/h6>\r\n\r\n<\/div>\r\n<div class=\"card\">\r\n    <div class=\"card-img\">\r\n        <a class=\"videolink\" href=\"https:\/\/www.youtube.com\/watch?v=HQCij9YvwNs\" data-src=\"https:\/\/www.youtube.com\/embed\/HQCij9YvwNs?modestbranding=1&rel=0&controls=1&showinfo=0&html5=1&autoplay=1\"\r\n            style=\"background-image: url(https:\/\/i.ytimg.com\/vi\/HQCij9YvwNs\/maxresdefault.jpg)\">\r\n        <\/a>\r\n    <\/div>\r\n            \r\n    <h6 class=\"counter text-center  text-white\" style=\"color:  #1C315A  !important;\">\r\n        <span class=\"bold\"> 4 <\/span> \/  5\r\n    <\/h6>\r\n\r\n<\/div>\r\n<div class=\"card\">\r\n    <div class=\"card-img\">\r\n        <a class=\"videolink\" href=\"https:\/\/www.youtube.com\/watch?v=BZPhIQhbzDU\" data-src=\"https:\/\/www.youtube.com\/embed\/BZPhIQhbzDU?modestbranding=1&rel=0&controls=1&showinfo=0&html5=1&autoplay=1\"\r\n            style=\"background-image: url(https:\/\/i.ytimg.com\/vi\/BZPhIQhbzDU\/maxresdefault.jpg)\">\r\n        <\/a>\r\n    <\/div>\r\n            \r\n    <h6 class=\"counter text-center  text-white\" style=\"color:  #1C315A  !important;\">\r\n        <span class=\"bold\"> 5 <\/span> \/  5\r\n    <\/h6>\r\n\r\n<\/div>\r\n            <\/div>\r\n            <div class=\"col col-md-auto section-link text-uppercase px-2 d-md-none flex-row-reverse d-flex\"\r\n                style=\"margin: -14px 12px 10px 8px;\">\r\n                    <h5 class=\"m-0 After-text-white\" style=\"color:  #1C315A  !important;\">\r\n    <a href=\"https:\/\/www.youtube.com\/playlist?list=PLRKA1an--trf2syLdIVmUe1VzTZVm6FCW\"\r\n        style=\"color: #1C315A  !important;\">\r\n            Tov\u00e1bbi vide\u00f3k\r\n    <\/a>\r\n<\/h5>\r\n                <div class=\"col section-divider px-0 mx-2\" style=\"margin-top: 7px;\"><\/div>\r\n            <\/div>\r\n        <\/div>\r\n    <\/div>\r\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>TOPIC Systemic Treatments of Metastatic Prostate Cancer. VISION Patients having the best treatment option for metastatic prostate cancer. MISSION Finding the drug that significantly improves the quality of life of patients. PROJECT TITLE 1 Investigating the efficacy and safety of abiraterone and enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. &hellip;<\/p>\n","protected":false},"author":101929,"featured_media":6042,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7,52],"tags":[10],"class_list":["post-3412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-phd-hallgato","category-year-2-gynecology-urology","tag-gynecology-urology"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/3412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/users\/101929"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/comments?post=3412"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/3412\/revisions"}],"predecessor-version":[{"id":8685,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/3412\/revisions\/8685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/media\/6042"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/media?parent=3412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/categories?post=3412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/tags?post=3412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}